West Pharmaceutical Services (WST) EBITDA Margin (2009 - 2026)
West Pharmaceutical Services recorded quarterly EBITDA Margin of 20.96% in Q1 2026, up 7.75% quarter-over-quarter from 19.45% in Q4 2025, and up 563.0% year-over-year from 3.16% in Q1 2025.
West Pharmaceutical Services' EBITDA Margin history runs 18 years deep, the most recent figure standing at 20.96% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 563.0% year-over-year to 20.96%; the TTM figure through Mar 2026 stood at 20.34% (up 120.0% YoY), while the FY2025 annual figure was 19.03%, down 67.0% from the prior year.
- EBITDA Margin came in at 20.96% for Q1 2026 at West Pharmaceutical Services, up from 19.45% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 29.61% in Q2 2022 to a low of 15.33% in Q1 2025.
- A 5-year average of 21.65% and a median of 21.31% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 688 bps in 2022 and soared 563 bps in 2026, its largest moves.
- West Pharmaceutical Services' EBITDA Margin stood at 18.3% in 2022, then advanced by 20 bps to 21.98% in 2023, then decreased by 3 bps to 21.31% in 2024, then declined by 9 bps to 19.45% in 2025, then advanced by 8 bps to 20.96% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 20.96%, 19.45%, and 20.83% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | -1.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.96% |
| Dec 31, 2025 | 19.45% |
| Sep 30, 2025 | 20.83% |
| Jun 30, 2025 | 20.05% |
| Mar 31, 2025 | 15.33% |
| Dec 31, 2024 | 21.31% |
| Sep 30, 2024 | 21.60% |
| Jun 30, 2024 | 17.97% |
| Mar 31, 2024 | 17.66% |
| Dec 31, 2023 | 21.98% |
| Sep 30, 2023 | 23.72% |
| Jun 30, 2023 | 24.21% |
| Mar 31, 2023 | 21.67% |
| Dec 31, 2022 | 18.30% |
| Sep 30, 2022 | 27.11% |
| Jun 30, 2022 | 29.61% |
| Mar 31, 2022 | 26.35% |
| Dec 31, 2021 | 25.18% |
| Sep 30, 2021 | 25.68% |
| Jun 30, 2021 | 29.20% |
| Mar 31, 2021 | 26.18% |
| Dec 31, 2020 | 20.01% |
| Sep 30, 2020 | 18.10% |
| Jun 30, 2020 | 19.65% |
| Mar 31, 2020 | 17.90% |
| Dec 31, 2019 | 16.60% |
| Sep 30, 2019 | 14.76% |
| Jun 30, 2019 | 17.14% |
| Mar 31, 2019 | 15.94% |
| Dec 31, 2018 | 15.57% |
| Sep 30, 2018 | 14.08% |
| Jun 30, 2018 | 13.47% |
| Mar 31, 2018 | 12.85% |
| Dec 31, 2017 | 14.53% |
| Sep 30, 2017 | 15.80% |
| Jun 30, 2017 | 10.56% |
| Mar 31, 2017 | 15.60% |
| Dec 31, 2016 | 13.78% |
| Sep 30, 2016 | 13.62% |
| Jun 30, 2016 | 15.77% |
| Mar 31, 2016 | 8.29% |
| Dec 31, 2015 | 12.57% |
| Sep 30, 2015 | -1.02% |
| Jun 30, 2015 | 10.87% |
| Mar 31, 2015 | 14.23% |
| Dec 31, 2014 | 12.75% |
| Sep 30, 2014 | 12.36% |
| Jun 30, 2014 | 14.67% |
| Mar 31, 2014 | 11.33% |
| Dec 31, 2013 | 10.77% |
| Sep 30, 2013 | 11.61% |
| Jun 30, 2013 | 12.34% |
| Mar 31, 2013 | 12.76% |
| Dec 31, 2012 | 9.80% |
| Sep 30, 2012 | 8.66% |
| Jun 30, 2012 | 10.96% |
| Mar 31, 2012 | 13.18% |
| Dec 31, 2011 | 9.14% |
| Sep 30, 2011 | 8.89% |
| Jun 30, 2011 | 9.03% |
| Mar 31, 2011 | 9.75% |
| Dec 31, 2010 | 2.13% |
| Sep 30, 2010 | 9.32% |
| Jun 30, 2010 | 10.82% |
| Mar 31, 2010 | 10.52% |
| Dec 31, 2009 | 7.40% |
| Sep 30, 2009 | 10.00% |
| Jun 30, 2009 | 11.00% |